Gradientech Announces Notice of Allowance from USPTO
Gradientech today announces that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 14/903,032, “Use of Fluidic Device”. The patent application covers the proprietary minimum inhibitory concentration (MIC) determination of a bacterial sample within a microfluidic controlled environment that is part of the technology platform of the Company’s diagnostic system QuickMIC™ for ultra-rapid AST in development.
Next-generation antimicrobial susceptibility testingTake a look at our E-book